TY - JOUR A1 - Pispati, Ameet A1 - Garg, Parag A1 - Patil, Nikhil A1 - Savedekar, Abhijeet A1 - Jaiswal, Nitin A1 - Kumar, Animesh T1 - Is intraarticular administration of tranexamic acid better than its intravenous administration in reducing blood loss after total knee arthroplasty? Y1 - 2013/7/1 JF - Journal of Orthopaedics and Allied Sciences JO - J Orthop Allied Sci SP - 28 EP - 32 VL - 1 IS - 2 UR - https://www.joas.in/article.asp?issn=2319-2585;year=2013;volume=1;issue=2;spage=28;epage=32;aulast=Pispati DO - 10.4103/2319-2585.125039 N2 - Context: It has been well-established now that intravenous (IV) tranexamic acid (TXA) is a potent agent to control postoperative blood loss following total knee arthroplasty (TKA). Recently, intraarticular administration of this agent has also shown good efficacy for the same. Aims: Comparison of postoperative blood loss between IV and topical administration of TXA in TKAs. Materials and Design: Eighty-six TKAs on knees were included in this study. Randomization was done so that 40 TKA received 1 g of IV TXA, while 46 had intraarticular administration of 1 g TXA. Subjets and Methods: We compared the postoperative blood loss by calculating the difference in pre- and postop hemoglobin and need for blood transfusion. Functional assessment was done on basis of Western Ontario McMaster Osteo-Arthritis Index (WOMAC) scores and complications like postoperative infection, oozing from the wound site and thromboembolic manifestations. Results: Blood loss was significantly less in the intraarticular administration group as compared to the IV injection group. Total blood loss, blood transfusion group, and drain output was also less but the difference was not significant. The functional assessment (WOMAC) scores were equivocal and so were the complications including thromboembolic manifestations (two cases each of deep vein thrombosis (DVT) and no cases of pulmonary embolism (PE)). Conclusion: Intraarticular administration of TXA to prevent postoperative blood loss in TKA is a safe and effective alternative/adjunct to its IV administration. ER -